[Recommendations for diagnosis and treatment of systemic lupus erythematosus].

Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 16210490R Publication Model: Print Cited Medium: Print ISSN: 0578-1426 (Print) Linking ISSN: 05781426 NLM ISO Abbreviation: Zhonghua Nei Ke Za Zhi Subsets: MEDLINE

Publication: : Beijing : Zhonghua yi xue hui
Original Publication: Beijing : Zhonghua yi xue hui Nei ke xue hui

Lupus Erythematosus, Systemic*/diagnosis ; Lupus Erythematosus, Systemic*/therapy ; Lupus Erythematosus, Systemic*/complications ; Rheumatology*; Humans ; Prognosis ; China ; Severity of Illness Index

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with complicated pathogenesis and diverse clinical manifestations. The current recommendations of the Chinese Rheumatology Association are based on a comprehensive investigation of evidence based medicine, domestic and international guidelines for SLE, and experts' proposals, and aim to provide a more scientific and authoritative reference for the diagnosis and management of SLE. The recommendations focus on four aspects; clinical manifestations, laboratory evaluation, diagnosis and disease assessment, and disease treatment and monitoring. The goal of the recommendations is to standardize the diagnosis and treatment of SLE in China so as to improve the prognosis of SLE patients.

Local Abstract: [Publisher, Chinese] 系统性红斑狼疮（SLE）是一种系统性自身免疫病，其发病机制复杂、临床表现多样。为SLE的诊疗提供更为科学、权威的参考依据，中华医学会风湿病学分会在充分参考各级循证医学证据、国内外权威诊治指南和专家建议的基础上，制定了本规范，从临床表现、辅助检查、诊断与评估、治疗与监测四个方面对SLE的规范化诊治进行详细阐述，旨在提高广大风湿免疫科医生诊治SLE的科学性和规范性，改善患者预后。.

Date Created: 20230703 Date Completed: 20230704 Latest Revision: 20230704

20230704

10.3760/cma.j.cn112138-20221027-00793

37394847